Scientific Partner
ReGenera R&D International for Aging Intervention is a no-profit scientific organization gathering highly experienced and reputed basic science scientists and clinicians. They all share an outstanding publications-endowed career in the field of biomedical sciences dedicated to aging process and intervention to fight against disease-accelerated senescence up to ideally affect biological aging per sè. Members of ReGenera R&D International for Aging Intervention moved pioneer steps as first in Italy already 10 years ago, by bringing in strictly EB DNA and RNA gene testing (cooperating with a cutting edge Genomic lab in Korea) into life-style preventive medicine protocols and in 1998 getting an international award on functional genomics for this. ReGenera R&D International for Aging Intervention has already its own CV of over 70 publications, 12 books chapters and 20 lectures at McGill, Texas W. Keio, Sendai, Kumamoto, Kanazawa and Harvard University while been granted a great deal of research grants. We have also established solid scientific relationships with prime USA, Canadian, Kazaki, Indian, Chinese, Japanese, Russian and Egyptian prime universities and research centers. Recently, ReGenera R&D International for Aging Intervention has a set a long standing cooperation with VCC, Preventive Medical Promotion Foundation in Beijing, a fine Evidence-Based group hard working on validation studies on TCM, integrative medicine, functional food, microbiota while exploring applicable models of successful preventive/intervention approach in view of a large scale application, thus representing an unique private enterprise reality in China.
Our mission is also searching fund to support research scholarships. We also act as a full service Contract Research Organization supporting our clients with outstanding clinical research and staffing solutions services and we are also eager to build a team of high performing experimental/clinical research professionals. Moreover, our research activity is constantly aiming to identify novel drug/natural molecules targets while developing innovative treatment modalities able to serve for human health care in prevention and disease.
Note: Last but not least, ReGenera R&D International for Aging Intervention has nothing to do with the plethora of would-be “antiaging associations” which are merely commercial structures and, most important, do not produce or fund any proprietary research whatsoever.